Skip to main content
. 2025 Aug 11;17(8):1041. doi: 10.3390/pharmaceutics17081041
WHO World Health Organization
PD Parkinson’s disease
CNS central nervous system
BBB blood–brain barrier
AD Alzheimer’s disease
β-amyloid
GSK-3β glycogen synthase kinase-3β
CDK5 cyclin-dependent kinase 5
TREM2 Triggering Receptor Expressed on Myeloid cells 2
NLRP3 NOD-, LRR-, and pyrin domain-containing protein 3
SNCA synuclein alpha gene
PINK1 PTEN-induced kinase 1
GBA1 Glucocerebrosidase 1
ASOs antisense oligonucleotides
GDNF glial cell line-derived neurotrophic factor
ALS amyotrophic lateral sclerosis
C9orf72 chromosome 9 open reading frame 72
SOD1 superoxide dismutase 1
TDP-43 TAR DNA-binding protein 43
HD Huntington’s disease
HTT huntingtin
AAV adeno-associated virus
P-gp P-glycoprotein
BCRP breast cancer resistance protein
TfR transferrin receptor
IR insulin receptor
LRP1 low-density lipoprotein receptor-related protein 1
CSF cerebrospinal fluid
clogP calculated logP
PSA polar surface area
MPO multiparameter optimization
PET positron emission tomography
LAT1 L-type amino acid transporter 1
LNPs lipid nanoparticles
pKa acid dissociation constant
GMP Good Manufacturing Practices
PLGA-PEG poly(lactic-co-glycolic acid)–polyethylene glycol
RVG29 rabies virus glycoprotein 29
MSNs mesoporous silica nanoparticles
BDNF brain-derived neurotrophic factor
iPSC induced pluripotent stem cell
Fe3O4 iron(II,III) oxide
MSC mesenchymal stem cell
ROS reactive oxygen species
RGDyK arginylglycylaspartic acid-tyrosine-lysine
tMCAO transient middle cerebral artery occlusion
MMP-9 matrix metalloproteinase-9
Rx diagnostic and therapeutic
MRI magnetic resonance imaging
FcRn neonatal Fc receptor
AUC area-under-the-curve
PrP prion protein
siRNA small interfering RNA
CED Convection-Enhanced Delivery
VEE Venezuelan equine encephalitis
saRNA self-amplifying RNA
circRNA circular RNA
SpCas9-HF1 Streptococcus pyogenes Cas9-High Fidelity 1
ABE8e adenine base editor 8e
dCas9-KRAB-MeCP2 deactivated Cas9 fused to a Krüppel-associated box and methyl-CpG-binding protein 2
CAR Chimeric Antigen Receptor
IL-10 Interleukin-10
TNF-α tumor necrosis factor-alpha
IL-1β Interleukin-1 beta
CD14 Cluster of Differentiation 14
NSC neural stem cell
TK/GCV thymidine kinase/ganciclovir
FUS focused ultrasound
AADC aromatic L-amino acid decarboxylase
UPDRS Unified Parkinson’s Disease Rating Scale
AMF alternating magnetic field
TRPV1 transient receptor potential vanilloid 1
PCI photochemical internalization
FDA U.S. Food and Drug Administration
ARIA amyloid-related imaging abnormalities
PK–PD pharmacokinetic–pharmacodynamic
CARPA complement activation-related pseudo-allergy
pHEA poly(2-hydroxyethyl aspartamide)
CCM Chemistry, Controls, and Manufacturing
PDI polydispersity index
vg vector genomes
CEAs cost-effectiveness analyses
ICER incremental cost-effectiveness ratio
QALY quality-adjusted life-year
EMA European Medicines Agency
ATMP Advanced Therapy Medicinal Product
AI artificial intelligence